Effect of the cathepsin K inhibitor odanacatib on bone resorption biomarkers in healthy postmenopausal women: two double-blind, randomized, placebo-controlled phase I studies.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples